Intermittent fasting increased gut bacteria diversity, reduced inflammation, demyelination, and axonal damage in multiple sclerosis (MS) animal model.
“A small pilot trial in humans with MS showed many similar changes to the gut microbiome and blood adipokines such as leptin. The effects of fasting on immune cells included a reduction of pro-inflammatory IL-17-producing T cells and increased numbers of T regulatory cells which prevent autoimmunity.”